Home
>
US Stocks
>
DaVita HealthCare Partners Inc.

DaVita HealthCare Partners Inc. (DVA)

$92.42

-1.86

(-1.97%)▲

Market is closed - opens 7 PM, 31 May 2023

Performance

  • $92.16
    $94.55
    $92.42
    downward going graph

    0.28%

    Downside

    Day's Volatility :2.53%

    Upside

    2.25%

    downward going graph
  • $65.28
    $103.00
    $92.42
    downward going graph

    29.37%

    Downside

    52 Weeks Volatility :36.62%

    Upside

    10.27%

    downward going graph

Returns

PeriodDaVita HealthCare Partners Inc.
3 Months
14.61%
6 Months
25.35%
1 Year
-5.2%
3 Years
15.04%

Highlights

Market Capitalization
8.6B
Book Value
$9.11
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
5.31
PE Ratio
17.76
PEG Ratio
0.86
Wall Street Target Price
99.24
Profit Margin
4.41%
Operating Margin TTM
11.02%
Return On Assets TTM
4.75%
Return On Equity TTM
30.37%
Revenue TTM
11.7B
Revenue Per Share TTM
127.44
Quarterly Revenue Growth YOY
2.0%
Gross Profit TTM
3.4B
EBITDA
2.0B
Diluted Eps TTM
5.31
Quarterly Earnings Growth YOY
-0.22
EPS Estimate Current Year
6.72
EPS Estimate Next Year
7.26
EPS Estimate Current Quarter
1.14
EPS Estimate Next Quarter
1.49

Analyst Recommendation

Hold
    6%Buy
    56%Hold
    37%Sell
Based on 16 Wall street analysts offering stock ratings for DaVita HealthCare Partners Inc.(by analysts ranked 0 to 5 stars)
Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
1
1
00
Hold
9
9
8
Sell
6
6
6

Analyst Forecast

What analysts predicted

Upside of 7.38%

Current $92.42
Target $99.24

Company Financials

FY17Y/Y Change
Revenue
10.9B
↓ 26.24%
Net Income
663.6M
↓ 24.58%
Net Profit Margin
6.1%
↑ 0.13%
FY18Y/Y Change
Revenue
11.4B
↑ 4.86%
Net Income
159.4M
↓ 75.98%
Net Profit Margin
1.4%
↓ 4.7%
FY19Y/Y Change
Revenue
11.4B
↓ 0.14%
Net Income
811.0M
↑ 408.79%
Net Profit Margin
7.12%
↑ 5.72%
FY20Y/Y Change
Revenue
11.6B
↑ 1.42%
Net Income
773.6M
↓ 4.6%
Net Profit Margin
6.7%
↓ 0.42%
FY21Y/Y Change
Revenue
11.6B
↑ 0.59%
Net Income
978.5M
↑ 26.47%
Net Profit Margin
8.42%
↑ 1.72%
FY22Y/Y Change
Revenue
11.6B
↓ 0.08%
Net Income
560.4M
↓ 42.73%
Net Profit Margin
4.83%
↓ 3.59%
Q4 FY21Q/Q Change
Revenue
2.9B
↑ 0.19%
Net Income
187.5M
↓ 27.83%
Net Profit Margin
6.37%
↓ 2.47%
Q1 FY22Q/Q Change
Revenue
2.8B
↓ 4.29%
Net Income
162.1M
↓ 13.52%
Net Profit Margin
5.75%
↓ 0.62%
Q2 FY22Q/Q Change
Revenue
2.9B
↑ 3.88%
Net Income
224.8M
↑ 38.67%
Net Profit Margin
7.68%
↑ 1.93%
Q3 FY22Q/Q Change
Revenue
2.9B
↑ 0.75%
Net Income
105.4M
↓ 53.13%
Net Profit Margin
3.57%
↓ 4.11%
Q4 FY22Q/Q Change
Revenue
2.9B
↓ 1.08%
Net Income
68.1M
↓ 35.37%
Net Profit Margin
2.33%
↓ 1.24%
Q1 FY23Q/Q Change
Revenue
2.9B
↓ 1.51%
Net Income
115.5M
↑ 69.67%
Net Profit Margin
4.02%
↑ 1.69%
FY17Y/Y Change
Total Assets
18.9B
↑ 1.1%
Total Liabilities
14.1B
↑ 1.23%
FY18Y/Y Change
Total Assets
19.1B
↑ 0.86%
Total Liabilities
15.2B
↑ 8.1%
FY19Y/Y Change
Total Assets
17.3B
↓ 9.41%
Total Liabilities
15.0B
↓ 1.38%
FY20Y/Y Change
Total Assets
17.0B
↓ 1.87%
Total Liabilities
15.4B
↑ 2.87%
FY21Y/Y Change
Total Assets
17.1B
↑ 0.78%
Total Liabilities
16.2B
↑ 4.95%
FY22Y/Y Change
Total Assets
16.6B
↓ 3.23%
Total Liabilities
14.7B
↓ 9.16%
Q4 FY21Q/Q Change
Total Assets
17.1B
↓ 2.91%
Total Liabilities
16.2B
↓ 0.74%
Q1 FY22Q/Q Change
Total Assets
17.1B
↓ 0.2%
Total Liabilities
14.7B
↓ 9.31%
Q2 FY22Q/Q Change
Total Assets
17.1B
↑ 0.08%
Total Liabilities
14.9B
↑ 1.78%
Q3 FY22Q/Q Change
Total Assets
17.0B
↓ 0.81%
Total Liabilities
14.9B
↓ 0.34%
Q4 FY22Q/Q Change
Total Assets
16.6B
↓ 2.32%
Total Liabilities
14.7B
↓ 1.25%
Q1 FY23Q/Q Change
Total Assets
16.7B
↑ 0.96%
Total Liabilities
14.3B
↓ 2.68%
FY17Y/Y Change
Operating Cash Flow
1.9B
↓ 2.85%
Investing Cash Flow
-1.4B
↑ 13.74%
Financing Cash Flow
-766.3M
↓ 43.32%
FY18Y/Y Change
Operating Cash Flow
1.8B
↓ 7.12%
Investing Cash Flow
-1.0B
↓ 26.42%
Financing Cash Flow
-625.4M
↓ 18.39%
FY19Y/Y Change
Operating Cash Flow
2.1B
↑ 16.97%
Investing Cash Flow
3.0B
↓ 397.85%
Financing Cash Flow
-4.7B
↑ 651.01%
FY20Y/Y Change
Operating Cash Flow
2.0B
↓ 4.5%
Investing Cash Flow
-825.4M
↓ 127.56%
Financing Cash Flow
-1.8B
↓ 60.68%
FY21Y/Y Change
Operating Cash Flow
1.9B
↓ 2.43%
Investing Cash Flow
-784.7M
↓ 4.92%
Financing Cash Flow
-1.1B
↓ 41.36%
FY22Y/Y Change
Operating Cash Flow
1.6B
↓ 18.97%
Investing Cash Flow
-630.3M
↓ 19.67%
Financing Cash Flow
-1.1B
↑ 3.52%
Q4 FY21Q/Q Change
Operating Cash Flow
529.9M
↓ 6.54%
Investing Cash Flow
-336.5M
↑ 104.61%
Financing Cash Flow
-774.4M
↑ 66.83%
Q1 FY22Q/Q Change
Operating Cash Flow
322.2M
↓ 39.2%
Investing Cash Flow
-118.4M
↓ 64.83%
Financing Cash Flow
-341.6M
↓ 55.89%
Q2 FY22Q/Q Change
Operating Cash Flow
188.1M
↓ 41.61%
Investing Cash Flow
-144.9M
↑ 22.39%
Financing Cash Flow
-103.4M
↓ 69.73%
Q3 FY22Q/Q Change
Operating Cash Flow
710.5M
↑ 277.7%
Investing Cash Flow
-153.9M
↑ 6.2%
Financing Cash Flow
-445.3M
↑ 330.65%
Q4 FY22Q/Q Change
Operating Cash Flow
343.7M
↓ 51.62%
Investing Cash Flow
-630.3M
↑ 309.71%
Financing Cash Flow
-230.9M
↓ 48.14%
Q1 FY23Q/Q Change
Operating Cash Flow
462.6M
↑ 34.57%
Investing Cash Flow
-116.5M
↓ 81.51%
Financing Cash Flow
-275.9M
↑ 19.49%

Technicals Summary

Sell

Neutral

Buy

DaVita HealthCare Partners Inc. is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
DaVita HealthCare Partners Inc.
DaVita HealthCare Partners Inc.
2.25%
25.35%
-5.2%
15.04%
38.27%
HCA Holdings, Inc.
HCA Holdings, Inc.
-6.98%
9.97%
25.56%
142.96%
156.36%
Universal Health Services Inc.
Universal Health Services Inc.
-13.64%
-2.19%
5.42%
22.36%
11.31%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
DaVita HealthCare Partners Inc.
DaVita HealthCare Partners Inc.
17.76
17.76
0.86
6.72
0.3
0.05
0.0
9.11
HCA Holdings, Inc.
HCA Holdings, Inc.
13.31
13.31
1.37
18.16
0.21
0.11
0.01
-9.04
Universal Health Services Inc.
Universal Health Services Inc.
13.63
13.63
1.87
10.18
0.11
0.05
0.01
85.67
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
DaVita HealthCare Partners Inc.
DaVita HealthCare Partners Inc.
Hold
$8.6B
38.27%
17.76
4.41%
HCA Holdings, Inc.
HCA Holdings, Inc.
Buy
$72.7B
156.36%
13.31
9.42%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$9.0B
11.31%
13.63
5.05%

Institutional Holdings

  • Berkshire Hathaway Inc

    39.82%

  • Vanguard Group Inc

    6.75%

  • BlackRock Inc

    5.32%

  • State Street Corporation

    2.81%

  • LSV Asset Management

    2.14%

  • Amvescap Plc.

    2.03%

Company Information

DaVita Inc. is a health care provider focused on transforming care delivery to improve quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. Through DaVita Kidney Care, the company treats patients with chronic kidney failure and end stage kidney disease. DaVita is committed to bold, patient-centric care models, implementing the latest technologies and moving toward integrated care offerings for all. Through these efforts, DaVita has also become the largest provider of home dialysis in the country. As of December 31, 2020, DaVita served 204,200 patients at 2,816 outpatient dialysis centers in the United States. The company also operated 321 outpatient dialysis centers in ten countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere.

Organization
DaVita HealthCare Partners Inc.
Employees
70000
CEO
Mr. Javier J. Rodriguez
Industry
Health Services

Discover More

FAQs